Skip to main content
. 2023 Jul 21;23:124. doi: 10.1186/s12894-023-01292-9

Table 1.

Characteristic of bladder urothelial carcinoma patients

Covariates Type Total Test Train Pvalue
Age ≤ 65 159(39.45%) 78(38.81%) 81(40.1%) 0.870
> 65 244(60.55%) 123(61.19%) 121(59.9%)
Gender FEMALE 106(26.3%) 51(25.37%) 55(27.23%) 0.757
MALE 297(73.7%) 150(74.63%) 147(72.77%)
Grade High Grade 380(94.29%) 189(94.03%) 191(94.55%) 1.000
Low Grade 20(4.96%) 10(4.98%) 10(4.95%)
unknow 3(0.74%) 2(1%) 1(0.5%)
Stage Stage I 2(0.5%) 1(0.5%) 1(0.5%) 0.867
Stage II 127(31.51%) 63(31.34%) 64(31.68%)
Stage III 140(34.74%) 73(36.32%) 67(33.17%)
Stage IV 132(32.75%) 62(30.85%) 70(34.65%)
unknow 2(0.5%) 2(1%) 0(0%)
T T1 3(0.74%) 2(1%) 1(0.5%) 0.927
T2 117(29.03%) 60(29.85%) 57(28.22%)
T3 193(47.89%) 95(47.26%) 98(48.51%)
T4 57(14.14%) 29(14.43%) 28(13.86%)
unknow 33(8.19%) 15(7.46%) 18(8.91%)
M M0 194(48.14%) 100(49.75%) 94(46.53%) 1.000
M1 11(2.73%) 6(2.99%) 5(2.48%)
unknow 198(49.13%) 95(47.26%) 103(50.99%)
N N0 234(58.06%) 123(61.19%) 111(54.95%) 0.239
N1 46(11.41%) 25(12.44%) 21(10.4%)
N2 75(18.61%) 34(16.92%) 41(20.3%)
N3 6(1.49%) 1(0.5%) 5(2.48%)
unknow 42(10.42%) 18(8.96%) 24(11.88%)